Literature DB >> 33430241

Human Primary Dermal Fibroblasts Interacting with 3-Dimensional Matrices for Surgical Application Show Specific Growth and Gene Expression Programs.

Sarah Grossi1, Annalisa Grimaldi1, Terenzio Congiu2, Arianna Parnigoni1, Giampiero Campanelli3,4, Paola Campomenosi1.   

Abstract

Several types of 3-dimensional (3D) biological matrices are employed for clinical and surgical applications, but few indications are available to guide surgeons in the choice among these materials. Here we compare the in vitro growth of human primary fibroblasts on different biological matrices commonly used for clinical and surgical applications and the activation of specific molecular pathways over 30 days of growth. Morphological analyses by Scanning Electron Microscopy and proliferation curves showed that fibroblasts have different ability to attach and proliferate on the different biological matrices. They activated similar gene expression programs, reducing the expression of collagen genes and myofibroblast differentiation markers compared to fibroblasts grown in 2D. However, differences among 3D matrices were observed in the expression of specific metalloproteinases and interleukin-6. Indeed, cell proliferation and expression of matrix degrading enzymes occur in the initial steps of interaction between fibroblast and the investigated meshes, whereas collagen and interleukin-6 expression appear to start later. The data reported here highlight features of fibroblasts grown on different 3D biological matrices and warrant further studies to understand how these findings may be used to help the clinicians choose the correct material for specific applications.

Entities:  

Keywords:  3D-biomaterials; cell growth; gene expression; human primary fibroblasts; surgery

Year:  2021        PMID: 33430241      PMCID: PMC7825678          DOI: 10.3390/ijms22020526

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  44 in total

Review 1.  A review of available prosthetics for ventral hernia repair.

Authors:  Vidya Shankaran; Daniel J Weber; R Lawrence Reed; Fred A Luchette
Journal:  Ann Surg       Date:  2011-01       Impact factor: 12.969

2.  Do Processing Methods Make a Difference in Acellular Dermal Matrix Properties?

Authors:  Todd J Nilsen; Anouska Dasgupta; Yen-Chen Huang; Henry Wilson; Evangelia Chnari
Journal:  Aesthet Surg J       Date:  2016-10-03       Impact factor: 4.283

Review 3.  Reversal of myofibroblast differentiation: a review.

Authors:  XiaoHong Yang; Bo Chen; Tao Liu; XiaoHong Chen
Journal:  Eur J Pharmacol       Date:  2014-04-15       Impact factor: 4.432

4.  A polymerase chain reaction based method for detecting Mycoplasma/Acholeplasma contaminants in cell culture.

Authors:  J Tang; M Hu; S Lee; R Roblin
Journal:  J Microbiol Methods       Date:  2000-01       Impact factor: 2.363

Review 5.  Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.

Authors:  Rafael Kramann; Derek P DiRocco; Benjamin D Humphreys
Journal:  J Pathol       Date:  2013-11       Impact factor: 7.996

6.  Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation.

Authors:  Gary R Grotendorst; Matthew R Duncan
Journal:  FASEB J       Date:  2005-05       Impact factor: 5.191

Review 7.  Ventral hernia repair with synthetic, composite, and biologic mesh: characteristics, indications, and infection profile.

Authors:  Marisa Cevasco; Kamal M F Itani
Journal:  Surg Infect (Larchmt)       Date:  2012-08-22       Impact factor: 2.150

8.  Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets.

Authors:  K M Fries; M E Felch; R P Phipps
Journal:  Am J Respir Cell Mol Biol       Date:  1994-11       Impact factor: 6.914

9.  Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts.

Authors:  Mohan R K Dasu; Robert E Barrow; Marcus Spies; David N Herndon
Journal:  Burns       Date:  2003-09       Impact factor: 2.744

10.  CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis.

Authors:  Kenneth E Lipson; Carol Wong; Yuchin Teng; Suzanne Spong
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.